Waage Christian

CIK: 0001553179

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)17 (63.0%)

Compensation grants

Other (G, F, J, C, D, …)10 (37.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

GOSS

Gossamer Bio, Inc.

Officer

HRTX

HERON THERAPEUTICS, INC. /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (27 total)

GOSS
Gossamer Bio, Inc.
Aug 24, 2026
Award(A)
Stock Option (Right to Buy)
Direct
2.9M shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
70K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
60K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
157.5K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
126.7K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
47.7K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
506.3K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
440K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
375K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
125K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
157.5K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
157.5K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
126.7K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
60K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
47.7K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
70K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
506.3K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
440K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
375K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
GOSS
Gossamer Bio, Inc.
Mar 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
157.5K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 30, 2026
Award(A)
Direct
54K shares-
GOSS
Gossamer Bio, Inc.
Jan 2, 2026
Award(A)
Direct
84.5K shares-
GOSS
Gossamer Bio, Inc.
Oct 1, 2025
Award(A)
Direct
125K shares-
GOSS
Gossamer Bio, Inc.
Mar 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
440K shares-

		Type	Shares	Price		Ownership
Aug 24, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	2,900,026	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	70,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	60,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	157,500	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	126,667	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	47,667	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	506,250	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	440,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	375,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	125,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	157,500	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	157,500	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	126,667	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	60,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	47,667	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Disposition(D) Stock Option (Right to Buy)	70,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	506,250	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	440,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	375,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Mar 19, 2026	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	157,500	-	-	Direct
Jan 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A)	53,960	-	$0	Direct
Jan 2, 2026	GOSS Gossamer Bio, Inc.	Award(A)	84,500	-	$0	Direct
Oct 1, 2025	GOSS Gossamer Bio, Inc.	Award(A)	125,000	-	-	Direct
Mar 4, 2025	GOSS Gossamer Bio, Inc.	Award(A) Stock Option (Right to Buy)	440,000	-	-	Direct

1-25 of 27 transactions

About Christian Waage

Christian Waage (SEC CIK 0001553179) files insider reports with the SEC as EVP, Tech Ops and Admin of Gossamer Bio, Inc. (GOSS) and Director of HERON THERAPEUTICS, INC. /DE/ (HRTX).

Signal8 holds 8 ownership filings by Christian Waage, all Form 4s, filed between Feb 3, 2025 and Aug 26, 2026. Those filings report 27 transactions, from Jan 30, 2025 to Aug 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Christian Waage's filings is in SAN DIEGO, CA.

Recent filings by Christian Waage

Aug 24, 2026: Grant or award of GOSS derivative securities (Form 4, code A).
Mar 19, 2026: Grants or awards of GOSS derivative securities (5 lines, Form 4, code A).
Mar 19, 2026: Disposition to issuer transactions of GOSS derivative securities (10 lines, Form 4, code D).
Mar 19, 2026: Grants or awards of GOSS derivative securities (5 lines, Form 4, code A).
Jan 30, 2026: Grant or award of HRTX shares (Form 4, code A).

Other insiders filing for Gossamer Bio, Inc. (GOSS)

Milligan Sandra, Director
Daniel Thomas O, Director
Ciongoli Gregory Austin, Director
Drynan Skye, Director
Quisel John D, Director
Cox Russell J., Director

How to read Form 4 transaction codes